glp 1 agonists oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies The Impact of GLP-1 Receptor
Description
PlexusDx encourages patients to disclose all contraceptive methods when initiating semaglutide injection or other GLP-1 therapies
The risk of hypoglycemia is increased if the drug is used in combination with sulfonylureas or insulin
The most common adverse effects are gastrointestinal , occurring in 20-50% of patients and including nausea, vomiting, diarrhea, constipation, and abdominal pain
Tolerability: Tolerability: While the side effect profile of incretin mimetics is relatively mild (low rates of severe AEs
00360-0/asset/06397771-b461-4bfd-bc69-cd0a43d464aa/main.assets/fx1.jpg)
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.World Health Organization
